Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This is a non-randomized, open-label phase II trial of 40 patients with poor prognosis head
and neck cancer, defined as surgically unresectable and/or ≥N2b disease and judged
appropriate for non-surgical definitive therapy.